Kuhusu ALLOZYNE INC

Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week. Source: Wikipedia
SektaBiotechnology
Makao makuuSeattle, WA
Ilianzishwa2005
Muundo wa kisheriaC Corporation
HaliAmilifu

Mapitio

Bado hakuna mapitio. Umefanya kazi na ALLOZYNE INC? Kuwa wa kwanza kushiriki uzoefu wako.

Andika pitio →

Takwimu muhimu

Ingia ili kuona takwimu muhimu

Mapato, faida halisi na idadi ya wafanyakazi wa ALLOZYNE INC kwa miaka yote, pamoja na vyanzo vyake.

Ingia Fungua akaunti kwa barua pepe yako

Ni bure

Mahali

Seattle, WA

Je, hii ni kampuni yako?

Dai ukurasa huu bure kuongeza nembo, bidhaa, picha na kazi zako, na kujibu mapitio.

Dai ukurasa huu

Shiriki kampuni hii

ALLOZYNE INCBiotechnologyhttps://heelky.com/explore/companies/allozyne-inc-64owvf45/

Nakili kiungo

Shiriki kwenye

Msimbo wa QR

Uchanganue kwa kamera ya simu ili kufungua ukurasa huu, au uupakue kwa ajili ya kipeperushi, slaidi au beji.

Jiunge na Heelky kuunganisha, kuajiri na kukua

Unda akaunti ya bure kutuma ujumbe kwa watu, kuomba kazi na kuchapisha misheni.

Jiunge sasa — ni bure

Chagua lugha yako

Heelky itakumbuka chaguo lako.

Lugha nyingine

Lugha zinazopatikana: 70 Kuhusu lugha kwenye Heelky